MedTrace Logo

Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort

NCT02641171 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2018-07-12

No results posted yet for this study

Summary

This study evaluates the use of exhaled air analysis as tool to monitor the disease activity in Crohn's Disease (CD). This study is a validation of the previous findings. In this study the participant will be asked to donate exhaled air, blood samples and fecal samples. The breath samples will be used to measure various volatile metabolites in breath. The breath air will be next used to validate the previous findings. The blood samples will be used to define the origin of volatile metabolites in breath. Finally, the potential of exhaled breath analysis as non-invasive marker of diseases activity will be compared to established fecal calprotectin.

Conditions

Interventions

OTHER

Specimen sampling

exhaled air samples blood samples fecal samples

Sponsors & Collaborators

  • Maastricht University

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Agnieszka Smolinska, PhD · Dartmouth/Maastricht University

  • Corey A Siegel, PhD,MD · Dartmouth-Hitchcock Medical Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-10-04
Completion
2016-10-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02641171 on ClinicalTrials.gov